Browse by author
Lookup NU author(s): Dr Dina Tiniakos, Dr John Anderson, Dr Mary Robinson, Professor David Neal
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Objective To investigate c-jun oncoprotein expression in transitional cell carcinomas (TCCs) of the urinary bladder and to determine its relationship to tumour grade and stage, and to the expression of epidermal growth factor receptor (EGFR), c-erbB-2 and p53 oncoproteins. Materials and methods The expression of c-jun was studied using immunohistochemistry in a series of 48 TCCs of known EGFR, c-erbB-2 and p53 status. Results Forty-four of 48 (92%) tumours showed c-jun specific nuclear immunoreactivity of variable intensity. The intensity of c-jun immunostaining was significantly related to tumour stage (P=0.009) and EGFR status (P=0.01). There was no correlation between c-jun oncoprotein expression and c-erbB-2 or p53 immunoreactivity. c-jun expression was not related to clinical outcome in terms of patient survival or rate of tumour recurrence. Conclusion The c-jun oncoprotein is expressed in the majority of TCCs of the urinary bladder. There is a positive association between intense c-jun immunoreactivity and muscle invasive growth, and EGFR positivity in TCCs.
Author(s): Tiniakos DG, Mellon K, Anderson JJ, Robinson MC, Neal DE, Horne CHW
Publication type: Article
Publication status: Published
Journal: British Journal of Urology
Year: 1994
Volume: 74
Issue: 6
Pages: 757-761
ISSN (print): 1464-4096
ISSN (electronic): 1464-410X
URL: http://dx.doi.org/10.1111/j.1464-410X.1994.tb07121.x
DOI: 10.1111/j.1464-410X.1994.tb07121.x
PubMed id: 7827848
Altmetrics provided by Altmetric
